The TIA stroke module was evaluated within the FASTEST trial
(Efficacy and Safety of a TIA Electronic Support Tool)
Published in Neurology (Ranta A, Dovey S, Weatherall M, O'Dea D, Gommans J, Tilyard M. Neurology. 2015 Apr 14;84(15):1545-51)
Hypothesis
The implementation of the primary care based TIA/stroke electronic decisions
support tool can improve TIA guideline adherence and reduce the risk of early
recurrent stroke without compromising patient safety.
Evaluation
Multi-centre, single-blind, parallel, cluster randomized controlled trial (1:1) in New Zealand
comparing management with and without Mosaic Consultation electronic decision support. GP initial
diagnosis TIA or stroke (all included in analysis regardless of final diagnosis).
Outcomes
- Improved adherence to best practice guidelines. Improved counselling.
- Clinically important and statistically significant reductions in TIA or stroke at 90 days and any vascular event and death at 90 days.
- Significant cost savings (NZ$1,479 per patient).
- No increase of adverse safety events.
Click below to view a clinical module.